Formulations containing a glucocorticoid drug for the treatment of bronchopulmonary diseases
OwnerDavid Lewis, David Ganderton +3inventors
InventorsDavid Lewis, David Ganderton, Brian Meakin, Gaetano Brambilla, Alessandra Ferraris
Life of this patent
Estimating the term…
Abstract
The invention discloses formulations for administration through pressurized metered dose inhalers containing as active ingredient a glucocorticoid, in particular the (22R) epimer of budesonide, in solution in a hydrofluorocarbon propellant, a cosolvent and a suitable additive, and their use in the treatment of asthma and other bronchopulmonary disorders.
Claims9
A pharmaceutical formulation to be used in a metered dose aerosol inhaler, comprising the (22R) epimer of budesonide as active ingredient in a concentration comprised between 0.12% and 0.20% w/v in solution in a mixture consisting of a hydrofluoroalkane propellant, a cosolvent and a low volatility component.
Dependencies are inferred from the claim text.